MarketPeel
Insider Trading Intelligence
Pricing
…
SP

Sushil Patel

RVMD
DIRECTOR · REVOLUTION MEDICINES, INC. · CIK 0001860609
FILING MIX · LIFETIME54%/46%
BUYS
29
SELLS
25
TOTAL VALUE
$3.13M
COMPANIES
2
ACTIVE SINCE
May 2021
HOLDINGS NOW
773,528
AVG SELL PX
$18.91
TRADE KIND
SHOWING 54 / 54
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by Sushil Patel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+54.55%-0.46%+0.24%-0.69%+0.54%—
14d11+54.55%-1.79%+0.43%-2.21%-2.15%—
30d11+45.45%+1.46%+1.24%+0.23%+0.75%—
60d11+45.45%+7.21%+2.86%+4.36%+1.81%—
90d11+54.55%-1.08%+4.25%-5.33%-3.14%—
180d11+72.73%-8.00%+6.36%-13.86%-18.75%—
1y11(1 pending)+70.00%-22.53%+17.58%-40.12%-30.61%—
2y11(5 pending)+83.33%-15.74%+40.77%-56.51%-95.39%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RVMD · 26,036 shares · as of Jun 29, 2026
09,20018,40027,60036,8002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 25 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
300$183.17$55.0K26,936Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
881$192.61$169.7K21,656Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
100$188.57$18.9K23,678Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
900$184.59$166.1K26,036Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
2,955$37.54$110.9K27,236Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
858$186.92$160.4K24,078Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
1,100$185.90$204.5K24,936Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
2,955——13,000Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
600$190.55$114.3K23,078Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
300$187.83$56.3K23,778Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
541$191.87$103.8K22,537Jun 29, 2026Jul 1, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
3,127——3,127Jun 18, 2026Jun 23, 2026 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
1,191——24,281Jun 18, 2026Jun 23, 2026 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE
Chief Executive Officer
37,324$5.08$189.6K747,492May 18, 2026May 20, 2026 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
251,240——784,816Apr 1, 2026Apr 7, 2026 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
376,860——376,860Apr 1, 2026Apr 7, 2026 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
200,000——533,576Dec 19, 2025Dec 19, 2025 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE10b5-1
10b5-1 plan
10,000$11.13$111.3K333,576Dec 2, 2025Dec 4, 2025 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
3,142——23,090Jun 26, 2025Jun 30, 2025 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
11,574——11,574Jun 26, 2025Jun 30, 2025 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE
Chief Executive Officer
25,105$8.06$202.3K343,576May 20, 2025May 22, 2025 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
250,000——250,000Apr 1, 2025Apr 3, 2025 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
166,667——368,681Apr 1, 2025Apr 3, 2025 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE10b5-1
10b5-1 plan
10,000$12.42$124.2K202,014Dec 16, 2024Dec 18, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
5,000$54.14$270.7K19,948Oct 31, 2024Nov 4, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
5,000$24.84$124.2K24,948Oct 31, 2024Nov 4, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
5,000——13,400Oct 31, 2024Nov 4, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
2,155$16.80$36.2K22,103Jul 9, 2024Jul 10, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
2,155$44.00$94.8K19,948Jul 9, 2024Jul 10, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
2,155——32,490Jul 9, 2024Jul 10, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
16,700——16,700Jun 20, 2024Jun 24, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
4,800——20,500Jun 20, 2024Jun 24, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
4,248——19,948Jun 20, 2024Jun 28, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
15,955——15,955Jun 20, 2024Jun 28, 2024 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE
Chief Executive Officer
20,194$6.47$130.7K212,014May 16, 2024May 20, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE10b5-1
10b5-1 plan
2,155$37.00$79.7K15,700Apr 10, 2024Apr 12, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
2,155$16.80$36.2K17,855Apr 10, 2024Apr 12, 2024 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
2,155——34,645Apr 10, 2024Apr 12, 2024 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
83,335——232,208Apr 1, 2024Apr 3, 2024 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
250,000——250,000Apr 1, 2024Apr 3, 2024 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE10b5-1
10b5-1 plan
5,145$24.11$124.0K149,426Jun 13, 2023Jun 15, 2023 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE10b5-1
10b5-1 plan
553$23.44$13.0K148,873Jun 13, 2023Jun 15, 2023 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
18,400——18,400Jun 8, 2023Jun 12, 2023 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
5,200——15,700Jun 8, 2023Jun 12, 2023 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE
Chief Strategy Officer
15,575$18.05$281.1K154,571May 16, 2023May 18, 2023 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Apr 1, 2023Apr 4, 2023 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
40,000——170,146Apr 1, 2023Apr 4, 2023 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
36,800——36,800Jun 16, 2022Jun 17, 2022 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
10,500——10,500Jun 16, 2022Jun 17, 2022 ↗View →
REPL
REPLIMUNE GROUP, INC.
SALE
Chief Commercial Officer
10,687$14.59$155.9K130,146May 16, 2022May 18, 2022 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
78,750——78,750Apr 1, 2022Apr 5, 2022 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
52,500——140,833Apr 1, 2022Apr 5, 2022 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
125,000——125,000May 3, 2021May 5, 2021 ↗View →
REPL
REPLIMUNE GROUP, INC.
PURCHASEGRANT
Stock grant
88,333——88,333May 3, 2021May 5, 2021 ↗View →
Other insiders · RVMD
Loading peer insiders…
About this filer
CIK 0001860609
ROLE
Director
PRIMARY
RVMD
COMPANIES
2
ACTIVE SINCE
May 2021
MARKETPEEL · /INSIDER/0001860609DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback